Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Economic evaluation for the United Kingdom (UK) of systemic chemotherapies as first-line treatment for metastatic pancreatic cancer (MPC)

  • In: Poster presentation
  • At: Buenos Aires (Argentina) (2016)
  • Type: Poster
  • Poster code: POS-SAPS-001
  • By: ABRAHAM, Ivo (UNIVERSITY OF ARIZONA, Pharmacy Practice and Science, Tucson, United States)
  • Co-author(s): Mahdi Gharaibeh:Center for Health Outcomes and PharmacoEconomic Research,UNIVERSITY OF ARIZONA,Tucson,United States|Ivo Abraham:Center for Health Outcomes and PharmacoEconomic Research,UNIVERSITY OF ARIZONA,Tucson,United States;Arizona Cancer Center,UNIVERSITY OF ARIZONA,Tucson,United States
  • Abstract:

    NAB-P+GEM and FFX have shown superior survival efficacy over GEM alone as first-line treatment for MPC. Meta-analysis showed Statistical significant improvement in OS detected especially with CIS+GEM, CAP+GEM, or OX+GEM. 

    We used published direct and indirect efficacy estimates of FOLFIRINOX v. other regimens from published network meta-analysis. A

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses